| Product Code: ETC13261348 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Infectious Disease Diagnostics Market was valued at USD 28.9 Billion in 2024 and is expected to reach USD 51.6 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The Global Infectious Disease Diagnostics Market is a rapidly growing sector driven by factors such as the increasing prevalence of infectious diseases, technological advancements, and the rising demand for accurate and timely diagnosis. The market includes various diagnostic methods such as molecular diagnostics, immunoassays, and rapid testing, with a focus on identifying pathogens such as bacteria, viruses, and parasites. Key players in the market are investing in research and development to launch innovative products and expand their product portfolios. Geographically, North America holds a significant share in the market, followed by Europe and the Asia Pacific region. The market is expected to continue growing due to the ongoing efforts to combat infectious diseases and the increasing awareness about the importance of early diagnosis for effective disease management.
The Global Infectious Disease Diagnostics Market is witnessing significant growth driven by the increasing prevalence of infectious diseases, technological advancements in diagnostic techniques, and the ongoing COVID-19 pandemic. Rapid diagnostic tests, molecular diagnostics, and point-of-care testing are gaining traction, enabling early and accurate detection of infectious diseases. The shift towards personalized medicine and the rising demand for rapid and accurate diagnostic solutions present opportunities for market expansion. Additionally, the growing investments in healthcare infrastructure in emerging economies, coupled with the rising awareness about the importance of early disease detection, are further driving market growth. Key players are focusing on developing innovative diagnostic solutions and expanding their product portfolios to capitalize on the expanding market opportunities.
The Global Infectious Disease Diagnostics Market faces several challenges, including limited access to diagnostic testing in remote or underdeveloped regions, high costs associated with advanced diagnostic technologies, and the need for continuous innovation to keep pace with evolving pathogens and drug resistance. Regulatory hurdles, such as lengthy approval processes for new diagnostic tests, also present obstacles for market growth. Additionally, the lack of awareness about the importance of early and accurate diagnosis of infectious diseases among healthcare providers and patients can hinder the adoption of diagnostic solutions. Addressing these challenges requires collaboration between industry stakeholders, policymakers, and healthcare organizations to improve access to testing, reduce costs, enhance regulatory frameworks, and promote education on the benefits of timely disease detection.
The Global Infectious Disease Diagnostics Market is primarily driven by factors such as the increasing prevalence of infectious diseases worldwide, the growing demand for rapid and accurate diagnostic tests, and the advancements in diagnostic technologies. Additionally, the rising awareness about the importance of early disease detection and the initiatives undertaken by governments and healthcare organizations to control and prevent infectious diseases are contributing to the market growth. Moreover, the ongoing research and development activities focused on developing innovative diagnostic solutions, along with the expanding healthcare infrastructure in developing countries, are further propelling the market. Overall, the need for effective diagnostic tools to combat infectious diseases, coupled with the increasing investments in healthcare infrastructure, is expected to drive the growth of the Global Infectious Disease Diagnostics Market.
Government policies related to the Global Infectious Disease Diagnostics Market typically focus on standardizing diagnostic testing procedures, ensuring the availability of reliable and accurate diagnostic tools, and promoting international collaboration for disease surveillance and control. Governments often allocate funding to support research and development in infectious disease diagnostics, as well as to aid in the deployment of diagnostic technologies in healthcare settings. Regulatory bodies may also establish guidelines for the approval and use of diagnostic tests to ensure their safety and effectiveness. Additionally, public health agencies work closely with industry stakeholders to monitor disease trends, facilitate data sharing, and coordinate responses to disease outbreaks, with the overall goal of improving global health security and reducing the burden of infectious diseases.
The Global Infectious Disease Diagnostics Market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnostic tests, and the advancements in technology leading to the development of innovative diagnostic solutions. The market is also likely to benefit from the rising awareness about the importance of early disease detection and the increased investments in healthcare infrastructure in both developed and developing countries. Additionally, the ongoing global efforts to combat infectious diseases such as COVID-19 are expected to further boost the demand for diagnostic tests. Overall, the market is projected to experience steady expansion, with a focus on point-of-care testing, molecular diagnostics, and automation to enhance efficiency and accuracy in disease diagnosis.
The Global Infectious Disease Diagnostics Market is witnessing varying trends across different regions. In Asia, the market is driven by the high prevalence of infectious diseases, increasing healthcare expenditure, and growing awareness about early disease detection. North America leads the market due to advanced healthcare infrastructure, technological advancements, and high adoption rates of diagnostic tests. Europe follows a similar trend with a focus on research and development activities in diagnostics. In the Middle East and Africa, the market is poised for growth due to improving healthcare facilities and rising government initiatives for disease control. Latin America is experiencing growth with increasing investments in healthcare infrastructure and a rising burden of infectious diseases. Overall, the market in these regions is expected to expand further with the increasing focus on preventive healthcare and rapid diagnostic technologies.
Global Infectious Disease Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Infectious Disease Diagnostics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Infectious Disease Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Infectious Disease Diagnostics Market - Industry Life Cycle |
3.4 Global Infectious Disease Diagnostics Market - Porter's Five Forces |
3.5 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.7 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By Type of Testing, 2021 & 2031F |
3.8 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.10 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.11 Global Infectious Disease Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Infectious Disease Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Infectious Disease Diagnostics Market Trends |
6 Global Infectious Disease Diagnostics Market, 2021 - 2031 |
6.1 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Reagents, Kits, and Consumables, 2021 - 2031 |
6.1.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.4 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Software & Services, 2021 - 2031 |
6.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Laboratory Testing, 2021 - 2031 |
6.2.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By PoC Testing, 2021 - 2031 |
6.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Immunodiagnostics, 2021 - 2031 |
6.3.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031 |
6.3.4 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Clinical Microbiology, 2021 - 2031 |
6.3.5 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology, 2021 - 2031 |
6.3.6 Global Infectious Disease Diagnostics Market, Revenues & Volume, By DNA Sequencing & Next-generation Sequencing, 2021 - 2031 |
6.3.7 Global Infectious Disease Diagnostics Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.3.8 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Other Technologies, 2021 - 2031 |
6.4 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.4.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By HIV, 2021 - 2031 |
6.4.4 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Hospital-acquired Infections, 2021 - 2031 |
6.4.5 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Mosquito-borne Diseases, 2021 - 2031 |
6.4.6 Global Infectious Disease Diagnostics Market, Revenues & Volume, By HPV, 2021 - 2031 |
6.4.7 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Chlamydia trachomatis, 2021 - 2031 |
6.4.8 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Other Infectious Diseases, 2021 - 2031 |
6.5 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Blood, Serum, and Plasma, 2021 - 2031 |
6.5.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Urine, 2021 - 2031 |
6.5.4 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Other Sample Types, 2021 - 2031 |
6.6 Global Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.6.3 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.6.4 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.6.5 Global Infectious Disease Diagnostics Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 North America Infectious Disease Diagnostics Market, Overview & Analysis |
7.1 North America Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.4 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
7.5 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.7 North America Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.8 North America Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Infectious Disease Diagnostics Market, Overview & Analysis |
8.1 Latin America (LATAM) Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
8.4 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
8.5 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.6 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
8.7 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
8.8 Latin America (LATAM) Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Infectious Disease Diagnostics Market, Overview & Analysis |
9.1 Asia Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
9.4 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
9.5 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.6 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
9.7 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
9.8 Asia Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Infectious Disease Diagnostics Market, Overview & Analysis |
10.1 Africa Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
10.4 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
10.5 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.6 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
10.7 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
10.8 Africa Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Infectious Disease Diagnostics Market, Overview & Analysis |
11.1 Europe Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
11.4 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
11.5 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.6 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
11.7 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
11.8 Europe Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Infectious Disease Diagnostics Market, Overview & Analysis |
12.1 Middle East Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
12.4 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By Type of Testing, 2021 - 2031 |
12.5 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.6 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
12.7 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
12.8 Middle East Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Infectious Disease Diagnostics Market Key Performance Indicators |
14 Global Infectious Disease Diagnostics Market - Export/Import By Countries Assessment |
15 Global Infectious Disease Diagnostics Market - Opportunity Assessment |
15.1 Global Infectious Disease Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Infectious Disease Diagnostics Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
15.3 Global Infectious Disease Diagnostics Market Opportunity Assessment, By Type of Testing, 2021 & 2031F |
15.4 Global Infectious Disease Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.5 Global Infectious Disease Diagnostics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
15.6 Global Infectious Disease Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
15.7 Global Infectious Disease Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Infectious Disease Diagnostics Market - Competitive Landscape |
16.1 Global Infectious Disease Diagnostics Market Revenue Share, By Companies, 2024 |
16.2 Global Infectious Disease Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here